ArticleLeukemia2011

Targeted inhibition of mTORC1 and mTORC2 by active-site mTOR inhibitors has cytotoxic effects in T-cell acute lymphoblastic leukemia.

C Evangelisti et al.PubMed ↗Publisher ↗

No numbers read from the abstract.